Market Research Blog

To overcome the problems related to COVID-19, it is important to diagnose the ailment at an early stage of infection. According to the World Health Organization (WHO), more than 180 million positive cases of COVID-19 were diagnosed till June 2021. The rate of positive cases can be controlled with early diagnosis and treatment.

Request a Sample of this Report@ https://www.futuremarketinsights.com/reports/sample/rep-gb-13636

SARS-CoV-2 antigen rapid test kits are the most common type of test that accounted for value USD 2,903.0 Mn in 2020. It is widely accepted due to convenience, ease and rapid nature in the diagnosis process.

The demand for point of care testing is increasing due to advantages such as lower time requirements, at home services, and cost effectiveness. These factors are going to bolster the demand for point of care testing during the forecast period. For instance, on 28 July 2020, Roche announced the launch of the SARS-CoV-2 Rapid Antibody Test in collaboration with SD Biosensor Inc.

With the launch of vaccines and development of mass vaccination programs by governments, the number of COVID-19 cases is expected to drop by the end of 2021, however, it is expected that testing will continue even as lockdown in many countries will be lifted. Key players are focused on strengthening their mergers and acquisitions with new discoveries of technologies.

Key Takeaways from COVID-19 Testing Services Market Study

• SARS-CoV-2 antigen rapid test kits are expected to account for over 67% the Americas COVID-19 testing market share by 2031, owing to higher efficacy in diagnostics.
• Hospital pharmacies accounted for more than 32% of the market share in 2021. The soaring influx of patients for treatment and intensive care support has driven growth.
• Canada will reflect relatively steady growth with a 4.8% CAGR, driven by the matured, government funded healthcare system.
• The U.S. will reflect fast growth at a CAGR around 5.7% through 2021-2031. U.S. holds the lead owing to, high healthcare expenditure, and the presence of leading players.
• Brazil is the leading country in Latin America, estimated to account for about 54% of the regional share in 2021, supported by easier access to required technologies.

 Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-13636

“The shift in focus from testing to vaccination is expected to hamper market growth in the near future. However, the focus on testing for international travel, frequent testing of medical staff and testing for patients with flu like symptoms are expected to continue aiding market growth,” says the Future Market Insight analyst.

Want More Insights?

Future Market Insights brings the comprehensive research report on forecasted revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2016 to 2031. The global COVID-19 testing market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader. The study provides compelling insights on the COVID-19 testing treatment market on basis of the test type in detail, cover every aspect of the market such as Test type, sample type, distribution channel across North America and Latin America region.

Americas COVID-19 testing Market by Category Test Type:

• SARS-CoV-2 IgM/IgG Antibody Rapid Test Kits
• SARS-CoV-2 Antigen Rapid Test Kits
• Multiplex Real-Time RT-PCR Assay Kits

Sample Type:

• Blood
• Nasopharyngeal Swabs

Buy Complete Report@ https://www.futuremarketinsights.com/checkout/13636

Distribution Channel:

• Hospital Pharmacies
• Diagnostic Laboratories
• Retail Pharmacies
• Drug Store
• Online Sales Channels

Scientifically, it is a rigorous and highly regulated process that allows consumers to purchase OTC access to a growing range of medicines. For a medicine to be granted under OTC status, it must comply with the regulatory standards associated with its efficacy, have a wide safety margin, and bolster labelling to ensure proper usage of the product.

The increasing prevalence of diseases with common self-treatable symptoms, such as cold and flu, headaches, allergies, and others has fuelled the demand for OTC drugs. Thus, growing sales of nonprescription drugs have pushed pharmaceutical companies to focus on Rx to OTC switches to meet customer needs thereby gaining high revenue in the market.

It was observed in 2020, Rx-to-OTC activity was driven by growing regulatory approvals and increased OTC sales. The COVID-19 outbreak has restricted patients to visit hospitals and clinics suffering from common illnesses. Consequently, delays in prescribed medication have shifted the customer preference towards the OTC drug consumption. As a result, the COVID 19 outbreak bolstered the demand for OTC products, which in turn has supported the adoption of Rx-to-OTC switches.

The Food and Drug Administration (FDA) introduced the non-prescription safe use regulatory expansion (NSURE) panel in 2013 that has supported a new wave of Rx-to-OTC switches, with a focus on creating conditions for switches in new therapeutic classes.

The introduction of the panel aimed to promote switches which had gained consumer attention, which in turn has aided the demand for the OTC drugs in the market.

To remain ahead of your competitors, request for a sample – https://www.futuremarketinsights.com/reports/sample/rep-gb-9135

Key Takeaways from Rx-to-OTC Switches Market Study

• Allergy and respiratory drugs are anticipated to gain a revenue share of more than 25% with a CAGR of 5.7% owing to the rising prevalence of lifestyle-based ailments.
• Retail pharmacies are anticipated to grow at a CAGR of 5.1% over the forecast period owing to the rise of e-commerce and the procurement of cost-effective medicines.
• The  U.K. holds the lead in Europe, holding a share of over 33% owing to the implementation of favorable government policies.
• The U.S. will account for over 77% of the North America market by 2031, supported by a matured healthcare and pharmaceutical sector and favorable reimbursement policies.
• China is the largest and fastest growing market in East Asia estimated to account for close to 49% of the global market, owing to the country’s large-scale pharmaceutical requirements.

 “Increasing global prevalence of allergies and common illnesses such as flu, coupled with rising awareness for self-medication practices, are driving the growth of the global Rx-to-OTC switches market,” says the FMI analyst.

Who is Winning?

Rx to OTC switches have led the pharmaceutical companies to shift focus from patients to consumers in terms of end users. In addition to strategic collaborations, acquisitions, expansion, product launches, agreements and research sponsorships are the key strategies adopted by manufacturers to expand their research and development (R&D) capabilities increasing sales in wider geographical base to strengthen product portfolios in the Rx-to-OTC switches market.

For instance, in January 2021, Boehringer Ingelheim entered into a collaborative agreement with Google Quantum AI (Google), focusing on researching and implementing cutting-edge use cases for quantum computing in pharmaceutical research and development (R&D).

Rx to OTC Switch Market by Category

Drug Category

• Allergy and Respiratory
• Fungal Infections & Other Infections
• Overactive Bladder
• Oral Contraceptives
• Gastrointestinal Drugs
• Hair Loss Treatments
• Smoking Cessation
• Analgesic, Inflammation And Pain Management
• Others (Lice, Acne, Weight Loss, And Laxative)

Get a Tailored Made Report to Match Your requirements, Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-9135

Distribution Channel

• Retail Pharmacies
• Hospital Pharmacies
• Drug Stores
• Online Pharmacies

Region

• North America
• Latin America
• Europe
• East Asia
• South Asia
• Oceania
• The Middle East and Africa (MEA)

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006, Jumeirah Bay 2, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs

Some of the digital devices available in the market have advanced features such as connectivity to Bluetooth or smart countdown. Clearblue, First Response and E.P.T. are some of the most popular digital ovulation test kits brands available in the U.S. market.

Increasing purchasing power and growing consumer awareness about women’s health are the two factors expected to drive the growth of the digital ovulation test kits market in the U.S. Various states in the country are focusing on improving women health through various awareness and healthcare programs.

Request Sample @ https://www.futuremarketinsights.com/reports/sample/rep-gb-13241

For instance, the American pregnancy association along with its education partner Fairhaven Health LLC guides ovulation testing to couples trying to get pregnant. This is anticipated to boost the growth of the digital ovulation test kit market.

Rising first-time pregnancy demographics and decreasing fertility rates, along with rising levels of disposable income and growing advancements in ovulation testing are some of the major factors driving the growth of the digital ovulation test kit market in the U.S.

The COVID-19 pandemic has significantly affected the sale of digital ovulation test kits. The nationwide lockdown and disrupted supply chains have limited the availability of these products. The pandemic in the first few months of 2020 has negatively impacted the digital ovulation test kits market.

Key Takeaways from the U.S. Digital Ovulation Test Kits Market Study

• Branded test kits are expected to dominate the U.S. digital ovulation test kits market, rising at a CAGR of around 9.3%.
• Institutional sales are expected to witness significant growth with easier access to patients driving a CAGR of around 8.8%.
• Home based use of digital ovulation test kits to gain traction owing to lower stress for use through menstrual cycles.
• Relatively higher costs to potentially limit sales of digital variants of ovulation test kits in the country.

“Increasing consumer awareness about fertility monitoring parameters, along with high cost and low accuracy associated with fertility treatments are expected to aid the demand for digital ovulation test kits in the U.S. through the end of the forecast period in 2031,” says the FMI Analyst

Who is Winning?The U.S. market is set to expand strongly owing to the rising prevalence of fertility disorders and the adoption of digital ovulation test kits. Furthermore, the advancements in digital ovulation test kits are expected to boost market demand.

Manufacturers are currently focusing on designing novel offerings that can provide better results at a lower cost, while also providing simple and reliable outputs. Key manufacturers are signing strategic partnership agreement within the industry to expand their product portfolios across the U.S.

• In 2017, Sugentech, a major digital ovulation test kits manufacturer entered into a strategic partnership with CGETC, Inc., a consumer fulfilment and marketing company located in the U.S.

For in-depth insights, Download a PDF Brochure – https://www.futuremarketinsights.com/reports/brochure/rep-gb-13241

The business alliance aims to support the distribution of product portfolios across the country and emerging players are extending their partnership to strengthen their market presence.

• For instance, In February 2019 NFI Consumer Healthcare expanded the agreement with Callitas Health to distribute co-branded products such as NFI’s e.p.t, the leading Over-the-Counter (OTC) ovulation test kit in the U.S.

Key market players covered by FMI include Church & Dwight Co. Inc., Swiss Precision Diagnostics GmbH, Sugentech Inc., Gregory Pharmaceutical Holdings, Inc., iXensor Co. Ltd, Samplytics Technologies Private Limited, Bio-AMD, and others consolidating their positions through mergers, acquisitions and new product launches.

Want more Insights?

Future Market Insights brings the comprehensive research report on forecasted revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2016 to 2031. The U.S. digital ovulation test kits market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader. The study provides compelling insights on digital ovulation test kits market on basis of product in detail, cover every aspect of the market such as (Branded Test Kits and Private Label Test Kits), and distribution channel (Institutional Sales (Hospital Pharmacies, Gynecology Clinics, IVF Clinics and Maternity Care Centers) and Retail Sales (Retail Pharmacies, Drug Stores, Hypermarkets & Supermarkets and Online Sales)) in the U.S.

For in-depth competitive analysis, Buy Now – https://www.futuremarketinsights.com/checkout/13241

Digital Ovulation Test Kits Market by CategoryBy Product:

• Branded Test Kits
• Private Label Test Kits

By Distribution Channel:

• Institutional Sales
  • Hospital Pharmacies
  • Gynaecology Clinics
  • IVF Clinics
  • Maternity Care Centers

• Retail Sales
  • Retail Pharmacies
  • Drug Stores
  • Hypermarkets & Supermarkets
  • Online Sales

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 8-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006,
Jumeirah Bay 2,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs

Highlighting the key influencing factors, the study opines that growing diabetic population across the globe has increased the demand for compression stockings and diabetic socks. Moreover, innovations like NPWT (Negative Pressure Wound Therapy) have turned out to be the modus operandi for managing acute and chronic wounds. Also, advancements in pneumatic compression therapy have proven to be effective and safe in treating lymphedema (caused by HNC – head and neck cancer) as stated by “Supportive Care in Cancer”.

Get a Sample Copy of the Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-496

Key Takeaways from Compression Therapy Market Study

• The static compression therapy held the largest market share in 2019 and the trend is expected to continue in the forecast period (2020-2030)
• Chronic ulcers are expected to hold more than 69% of market share in terms of revenue in 2020
• Among all distribution channel, institutional sales is the leading segment followed by retail sales. Retail sales segment is anticipated to grow at CAGR of 6% over the forecast period
• North America and Europe are collectively expected to hold more than 67% of revenue share in 2020 while East Asia is expected to show greater growth potential in the forecast period.“Acquisitions and launch of compression products along with increasing demand for compression therapy offering increased mobility, enhance athletic performance and safety profiles are driving the growth of global compression therapy market” says the FMI Analyst 

Get a Tailored Made Report to Match Your requirements, Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-496

Expansion with Research: The Latest Trend

The compression therapy market players are onto the expansion spree to stand out.

For instance –

In May 2020, British Medical Journal published a study that stated that anti-embolism stockings are all the more effective with respect to DVT (deep vein thrombosis). This finding is bound to influence players to go for production of anti-embolism stockings in the forecast period

Avanos Medical Inc., in the year 2018, announced acquiring CoolSystems, Inc. The products post acquisition were marketed as “Game Ready”

Huntleigh Healthcare Ltd.’s IPC (Intermittent Pneumatic Compression) products under the “Hydroven” brand are a noteworthy addition to vascular assessment systems

Key Participant Insights

The global market is set to broaden its scope in the forecast period, stimulated by high prevalence rate of diabetes, rising geriatric population globally and adoption of advanced compression therapy systems which can be used as bi-layer and multi-layer for conventional treatment option. In addition to this, strict guidelines limits the design space for potential conceptual ideas and availability of alternate therapies has augmented the sales of compression products.

For in-depth insights, Download a PDF Brochure – https://www.futuremarketinsights.com/reports/brochure/rep-gb-496

The key market players covered by FMI include:

Paul Hartmann AG, Sigvaris AG, Cardinal Health Inc. and 3M Health Care Ltd. consolidating their positions through mergers, acquisitions and new product launches.

Key Segment

Product Type

• Pneumatic Compression Therapy
• Non-Segmented Pneumatic Compression Pumps
• Pneumatic Compression Sleeves
• Lower Pneumatic Compression Sleeves
• Upper Pneumatic Compression Sleeves
• Segmented Pneumatic Compression Pumps
• Segmented Pneumatic Compression Pumps with Calibrated Gradient
• Segmented Pneumatic Compression Pumps without Gradient
• Static Compression Therapy
• Anti-Embolism Stockings
• Compression Bandages
• Compression Garments
• Lower Compression Garments
• Upper Compression Garments

Indication

• Chronic Ulcers
• Venous Leg Ulcers
• Diabetic Foot Ulcers
• Pressure Ulcers
• Non-Healing Surgical Wounds
• Traumatic Wounds
• Burn Cases

Distribution Channel

• Institutional Sales
• Hospitals
• Clinics
• Ambulatory Surgical Centers
• Nursing Facilities
• Retail Sales
• Hospital Pharmacy
• Retail Pharmacy
• Online Sales

COPD (chronic obstructive pulmonary disease) is amongst the most life-threatening diseases, wherein breathlessness forms the very first symptom. The WHO states that the number of people affected by COPD crossed 250 Mn in 2019.

The US alone has more than 15 Mn cases (as per the American Lung Cancer Association). There isn’t any direct cure on records as of now. As such, symptomatic treat is being administered.

According to FMI’s analysis, manual resuscitator is sufficing at the moment. However, automation in this regard is bound to restrain the market in the years to come.

To remain ahead of your competitors, request for a sample – https://www.futuremarketinsights.com/reports/sample/rep-gb-2284

What’s with Infants and Neonates?

According to the WHO, in the year 2018, close to 2.5 Mn children died in the very first month of their life due to pre-term birth, infections, or birth asphyxia.

It further states that around 23% of infants were diagnosed with birth asphyxia in the same year. Resuscitation is a must in cases like these.

The trend mentioned above, apart from COPD, is expected to take the manual resuscitator market at a higher stride in the forecast period (2020-2030).

Key Takeaways

• Self-inflating bags accounted for the highest market share in 2019 as the usability is greater in emergency situations. Also, NCBI states that neonatal care could be best adhered to through self-inflating bags.
• Flow-inflating bag (better known as anaesthesia bag) is expected to witness an exponential growth between 2020 and 2030 as it finds its applications in intensive care units, wherein even a bit of fluctuation in oxygen delivery is uncalled for.
• Out-of-hospital cardiac arrests have been increasing worldwide. Around 395,000 such cases are seen in the US alone every single year. The National Academies of Sciences, Engineering and Medicine (US) has been conducting public workshops for improving strategies to survive cardiac arrests. This will also drive the demand for manual resuscitators as the primary course of treatment.
• The outbreak of Covid-19 has escalated the demand for manual resuscitators as breathlessness is one of the symptoms herein.

“Neonatal Care is the primary area of focus by the governments worldwide, along with heart-related ailments. This trend is bound to bolster the manual resuscitation market in the forecast period” – says the FMI analyst.

Key Participant InsightsThe global market is set to enhance its scope in the forecast period, due to rising number of cardiac arrests. In addition to this, cost-effectiveness is augmenting the sales of manual resuscitator.

The key market players covered by FMI include HUM Systems for Life, GE Healthcare, Covidien Plc, Hopkins Medical Product, Drager Medical AG and Co., Laerdal Medical, Me. Ber. Srl, Hill, Ambu A/S, Philips Healthcare, CareFusion, Weinmann, and Medline Industries.

Want more insights?Future Market Insights brings the comprehensive research report on forecasted revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2015 to 2030. The global manual resuscitator market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader. The study provides compelling insights on manual resuscitator market on the basis of type (flow-inflating resuscitator, self-inflating resuscitator, T-piece), modality (silicone, PVC, rubber), technology (pop-off valve, PEEP valve, others), type of patient (pediatric, adult, others (infants, neonates), application (COPD, cardiopulmonary arrest, others (asthma, anaesthesia), end-use (hospital, out-of-hospital (home care, community care, primary care), ASC, military, others (specialized diagnostic centres, specialized clinics) across seven major regions.

Get a Tailored Made Report to Match Your requirements, Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-2284

Key SegmentType

• flow-inflating resuscitator
• self-inflating resuscitator
• T-piece

Modality

• Silicone
• PVC
• rubber

Technology

• pop-off valve
• PEEP valve
• others

Type of Patient

• Pediatric
• Adult
• Others (Neonates and Infants)

End-Use

• hospital
• out-of-hospital (home care, community care, primary care)
• ASC
• Military
• others (specialized diagnostic centres, specialized clinics)

For in-depth insights, Download a PDF Brochure – https://www.futuremarketinsights.com/reports/brochure/rep-gb-2284

Geography

• North America
• Latin America
• Europe
• East Asia
• South Asia
• Oceania
• MEA

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006, Jumeirah Bay 2, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
LinkedIn| Twitter| Blogs
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com

Advancements in orthopedic braces and support market have offered umpteen benefits, bringing substantial improvements in average quality of life and lifespans.

Tech-driven innovation holds true potential for market players to enhance the understanding of patients, thus enabling at-scale convenience and individualized care.

The healthcare industry is embracing technological intervention with digital health, virtual health, and telehealth to treat patients.

Such trends are emerging as a potential disruptor in the orthopedic braces and support market, which has been facing the brunt of the COVID-19 pandemic.

Request Sample Copy of Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-12207
Key Takeaways of Orthopedic Braces and Support Market Study        

• The orthopedic braces and support market to grow at robust 6.1% CAGR through 2030
• Lower extremity products to capture around 70% revenue share; knee braces and supports to lead the way
• East and South Asia to represent potential growth avenues for market players

“Recent tech-driven innovations such as human torso simulator is opening door back brace innovations. The simulator allows development of new back braces that are optimized to restrict specific motions yet allowing for other movements. Moreover, it can assist with design of braces and supports with targeted constraint of movement,” says the analyst at FMI.

COVID-19 Impact on Orthopedic Braces and Support Market

The COVID-19 pandemic has affected every facet of the healthcare industry including, orthopedic braces and supports.

Regular orthopaedic practice has been considerably impacted by the pandemic.

Surgery schedules have been revamped, with elective cases being instantly delayed or cancelled and urgent cases demanding huge attention, particularly in suspected or confirmed COVID-19 cases.

This is having a measurable impact on inpatient management, accenting the need for dedicated personnel, patient quarantine and limited visiting hour regulation.

On the flip side, outpatient visits have been restricted to avoid contacts between patients and the hospital staff, with notable implications on post-operative quality of care delivery and healthcare professionals.

The pandemic has rapidly spurred the adoption of telehealth options such as performing non-urgent check-ups and post-operative visits via electronic mediums instead of in-person.

Visits are being organized by video or by phone. This sudden adoption of telemedicine has triggered a process that would have, otherwise, taken far longer to execute on such a global level.

Request a Complete TOC of this Report with figures: https://www.futuremarketinsights.com/toc/rep-gb-12207

Orthopedic Braces and Support Market – Competitive Intelligence

The global orthopedic braces and support market is slightly fragmented with presence of limited number of prominent players and large number of small- and medium-scale players. In order to sustain their customer base, market players are investing in product launches.

• Otto Bock Healthcare has rolled out Agilium® Vantage, a low-key, wraparound knee brace, that is developed for delivering prolonged pain relief for patients having mild unicompartmental osteoarthritis (OA)
• Breg Inc. has developed Breg Quantum™  OA for mild to severe OA in a bid to satiate the need for pain management in arthritic patients

In addition to this, market players are also cashing in on acquisitions in a bid to expand their regional foothold. For instance, 3M has taken on Acelity Inc. and its KCI subsidiaries across the world to expand its offerings in advanced wound care.

Want more insights?

FMI, in its new market research study, offers an unbiased assessment of the orthopaedic braces and support market which comprises global industry analysis for 2015–2019 and opportunity assessment for the 2020–2030. The report delivers complete analysis on orthopaedic braces and support market through three different categories – by product, by distribution channel, and region.

The global orthopaedic braces and support market study provides insights of pricing by different life cycle analysis, product life cycle, key market trends and technologies that are being implemented in the development of orthopaedic braces and supports and product adoption in various end-use industries

Contact Sales for Further Assistance in Purchasing this Report@ https://www.futuremarketinsights.com/checkout/12207

Orthopedic Braces and Support Industry Research Analysis

Orthopedic Braces and Support Market by Product:

• Upper Extremity Braces and Supports
  • Shoulder Braces and Supports
  • Neck Braces and Supports
  • Elbow Braces and Supports
  • Wrist Braces and Supports
  • Spinal Braces and Supports
• Lower Extremity Braces and Supports
  • Knee Braces and Supports
  • Ankle Braces and Supports
  • Hip Braces and Supports

Orthopedic Braces and Support Market by Distribution Channel:

• Institutional Sales
  • Hospitals
  • Orthopedic Clinics
  • Nursing Facilities
• Retail Sales
  • Online Sales
  • Retail Pharmacies
  • Drug Stores

Orthopedic Braces and Support Market by Region:

• North America Orthopedic Braces and Support Market
• Latin America Orthopedic Braces and Support Market
• Europe Orthopedic Braces and Support Market
• East Asia Orthopedic Braces and Support Market
• South Asia & Pacific Orthopedic Braces and Support Market
• Middle East & Africa (MEA) Orthopedic Braces and Support Market